NF-κB signaling driven by constitutive CD40 activation also cooperates with transgenic λ-Myc to induce lymphomas, but the tumors derived are aggressive activated DLBCL-like lymphomas rather than BLs [73]. The gene discussed is NFKB1; the disease is lymphoma.